Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (1): 61-62.
Previous Articles Next Articles
YUAN Qianqian1, TANG Kun2,*
Received:2018-06-11
Revised:2019-02-18
Online:2019-01-20
Published:2019-02-18
CLC Number:
YUAN Qianqian, TANG Kun. One Case of Erythroderma Induced by Teicoplanin for Injection[J]. Chinese Journal of Pharmacovigilance, 2019, 16(1): 61-62.
| [1] Nosbaum A, Nicolas J F.Glycopeptide-induced cutaneous adverse reaction[J]. Annales de dermatologie et de venereologie, 2010,137(5):341-342. [2] Ebrahimpour S, Mohammadi M, Gholami K.Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) with Teicoplanin: A Case Report[J]. Drug Saf, 2017,4(1):1-4. [3] Asero R.Teicoplanin-induced anaphylaxis[J]. Allergy, 2006,61(11):1370. [4] Yang L P, Zhang A L,Wang D D,et al.Stevens-Johnson syndrome induced by the cross-reactivity between teicoplanin and vancomycin[J]. Journal of Clinical Pharmacy and Therapeutics, 2014,39(4):442-445. [5] 张湘衡,陈忠平.抗癫痫新药左乙拉西坦[J]. 中国神经肿瘤杂志, 2010,8(2):120-123. [6] 应义,崔,张慧.抗癫痫药物研究现状与新进展[J]. 中国药业, 2012,21(20):111-112. [7] 包振宇,邹先彪.重症药疹的研究进展[J]. 实用皮肤病学杂志, 2015,8(2):112-118. [8] 金菊花. 剥脱性皮炎282例临床分析[D]. 吉林大学硕士学位论文, 2011:3. [9] Akhyani M, Ghodsi Z S, Toosi S, et al.Erythroderma: a clinical study of 97 cases[J]. BMC Dermatology, 2005, 5:5. [10] Sheen Y S, Chu C Y, Wang S H, et al.Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in Taiwan[J]. J Dermatolog Treat, 2009, 20(6): 340. [11] 刘秀琼,许娟.去甲万古霉素致严重剥脱性皮炎1例[J]. 中国执业药师, 2014,11(5):53-54. [12] 李奎宝,那开宪.去甲万古霉素致严重剥脱性皮炎一例[J]. 首都医药, 2006,13(10):49. [13] 吴琳,倪穗琴.万古霉素致剥脱性皮炎1例[J]. 广东药学, 2004,14(6):49. [14] Paul C, Janier M, Carlet J, et al.Erythroderma induced by teicoplanin[J]. Ann Dermatol Venereol, 1992,119(9):667-669. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
